Cape Sativa is a subsidiary of 3Sixty Global Solutions Group, an integrated Biotechnology and Healthcare Group. Cape Sativa uses a patented Nano Technology Platform that makes cannabinoids more water soluble, and more stable, with enhanced cellular absorption, for application in pharmaceuticals, medicinals, nutraceuticals, cosmeceuticals, beverages and edibles. The nanotechnology platform will revolutionise healthcare by providing new methods for disease prevention and treatment.
Cape Sativa was incorporated in 2022 in South Africa. The business plans to be incorporated in the United States of America as well.